Barclays PLC Enzo Biochem Inc Transaction History

Barclays PLC

$377 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.17 - $4.09 $18,985 - $24,495	-5,989 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$3.01 - $3.77 $2,733 - $3,423	908 Added 17.87%	5,989 $21,000
Q2 2021 Aug 13, 2021	SELL	$2.86 - $3.61 $91,683 - $115,725	-32,057 Reduced 86.32%	5,081 $16,000
Q1 2021 May 13, 2021	BUY	$2.61 - $4.08 $41,856 - $65,430	16,037 Added 76.0%	37,138 $128,000
Q4 2020 Feb 11, 2021	BUY	$1.82 - $2.61 $1,503 - $2,155	826 Added 4.07%	21,101 $53,000
Q3 2020 Nov 12, 2020	SELL	$2.02 - $3.02 $8,255 - $12,342	-4,087 Reduced 16.78%	20,275 $42,000
Q2 2020 Aug 12, 2020	BUY	$2.12 - $3.22 $20,678 - $31,407	9,754 Added 66.77%	24,362 $54,000
Q1 2020 May 13, 2020	SELL	$1.82 - $3.87 $55,275 - $117,535	-30,371 Reduced 67.52%	14,608 $37,000
Q4 2019 Feb 10, 2020	BUY	$2.57 - $3.68 $56,712 - $81,206	22,067 Added 96.31%	44,979 $118,000
Q3 2019 Nov 14, 2019	SELL	$3.01 - $4.0 $19,423 - $25,812	-6,453 Reduced 21.98%	22,912 $82,000
Q2 2019 Aug 14, 2019	BUY	$2.79 - $4.31 $47,204 - $72,920	16,919 Added 135.94%	29,365 $99,000
Q1 2019 May 15, 2019	BUY	$2.54 - $4.02 $31,455 - $49,783	12,384 Added 19974.19%	12,446 $34,000
Q4 2018 Feb 14, 2019	SELL	$2.46 - $4.2 $41,918 - $71,568	-17,040 Reduced 99.64%	62 $0
Q3 2018 Nov 14, 2018	BUY	$3.81 - $5.53 $52,875 - $76,745	13,878 Added 430.46%	17,102 $70,000
Q2 2018 Aug 14, 2018	SELL	$5.06 - $6.78 $36,988 - $49,561	-7,310 Reduced 69.39%	3,224 $16,000
Q1 2018 May 15, 2018	SELL	$5.43 - $8.36 $46,670 - $71,854	-8,595 Reduced 44.93%	10,534 $59,000
Q4 2017 Feb 14, 2018	BUY	$8.15 - $10.55 $7,921 - $10,254	972 Added 5.35%	19,129 $156,000
Q3 2017 Nov 14, 2017	BUY	$10.45 - $11.44 $189,740 - $207,716	18,157	18,157 $191,000

Others Institutions Holding ENZ

# of Institutions

Shares Held

15.4M

Call Options Held

2.3K

Put Options Held

Harbert Fund Advisors, Inc. Birmingham, AL

5.18M
Shares

$3.42 Million
3.43% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.53M
Shares

$1.67 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.88M
Shares

$1.24 Million
0.0% of portfolio
Potomac Capital Management, Inc.

1.48M
Shares

$977,949
3.63% of portfolio
Viex Capital Advisors, LLC Sunny Isles Beach, FL

1.33M
Shares

$880,756
9.62% of portfolio

View Full List

About ENZO BIOCHEM INC

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $32.2M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

More about ENZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account